Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge

We have previously shown in triple-negative breast cancer (TNBC) models that a triple therapy (TT) including intermittent cyclophosphamide (C), vinorelbine (V), and anti-PD-1 activates antigen-presenting cells (APC) and generates stem like-T cells able to control local and metastatic tumor progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Orecchioni, Stefania, Falvo, Paolo, Talarico, Giovanna, Mitola, Giulia, Bravetti, Giulia, Mancuso, Patrizia, Nicoli, Paola, Bertolini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095342/
https://www.ncbi.nlm.nih.gov/pubmed/37048617
http://dx.doi.org/10.3390/jcm12072535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095342/
https://www.ncbi.nlm.nih.gov/pubmed/37048617
http://dx.doi.org/10.3390/jcm12072535

Ejemplares similares